CG:600422 KPC Pharmaceuticals, Inc

KPC Pharmaceuticals, Inc., formerly Kunming Pharmaceutical Corp., is a China-based company principally engaged in manufacture, wholesaling and retailing of pharmaceuticals. The Company provides natural herbal medicines and chemical compound drugs, including drugs for central nervous systems, drugs for cardio and cerebral vascular diseases, anti-parasite drugs, antimicrobial drugs, anti-gout drugs, hormones and endocrine regulation drugs, drugs for hemorrhoids and anti-inflammatory drugs, among others. The Company also involves in pharmaceutical purchasing and distribution, as well as health supplements manufacturing. It distributes its products in domestic and overseas markets.

9.55 CNY
As of 01/28/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  12/07/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   7,362,665,984 CNY
Current dividend yield:   2.37%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy